Keywords: abbott, gains, fda, ok, once-daily, depakote, laboratories
Abbott gains FDA OK for once-daily Depakote
Article | 06 January 2003
Abbott Laboratories has announced that the US Food and DrugAdministration has approved its Depakote ER (divalproex sodium extended-release) tablets for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
